Press releases
-
-
-
-
-
Internal link ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
-
-
-
-
-
-
Internal link ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
-
-
Internal link ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
-
-
-
Internal link ProQR Announces Planned Changes to Board Composition
-
Internal link ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
-
-
-
Internal link ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
-
-
-
-
-